While genomics may be inching toward the clinic, from a business perspective, the research end-market remains the prime target for most entrepreneurs in the space, writes Art Wuster at his Sequenomics blog.

Wuster looked at 72 firms listed on the technology company database Crunchbase, all of which received at least some third-party funding, and found that 38 were companies with customers in research laboratories or in other genomic firms.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.